“Suspected Optic Nerve Dysfunction Associated with Semaglutide in a Non-Diabetic Obese Patient: A Case Report: Semaglutide Associated Optic Nerve Dysfunction”, J Diabesity, vol. 1, no. 2, p. 7, Feb. 2026, doi: 10.66381/jod.2026.002.